Table 1 Neuropsychological and demographic summary of participants.

From: Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia

 

Controls n = 20

subjective cognitive decline (SCD) n = 44

Mild cognitive impairment (MCI) n = 45

Probable AD (AD) n = 13

Group statistic

ACE-III (SD)

94.6(3.8)

91.7(4.9)

85.2(7.1)

79.2(6.2)

F(3,118) = 27.4 p < 0.0001

Age (SD)

67.4(8.3)

69.0(7.7)

71.1(7.1)

74.9(6.2)

F(3,118) = 3.3 p = 0.024

Sex

(% Female)

80

59

51

23

χ2 = 10.9, p = 0.012

Vascular risk factor ≥ 2 (%)

30

36

31

46

χ2 = 1.3, p = 0.739

  1. Addenbrooke’s Cognitive Examination-III (ACE-III) and age are tabulated as group mean (standard deviation). ANOVA result comparing ACE-III and age, and a χ2 test comparing frequency distributions of sex and aggregated vascular risk factor across groups, is reported in the last column. Vascular risk factor is an aggregated measure for hypertension, dyslipidaemia, diabetes, and smoking, with a score of 1 for presence or treatment of each factor (range 0 to 4). Post-hoc pair-wise tests revelated a significant difference in age between controls and AD (p = 0.03). Comparing ACE-III between groups in post-hoc tests, significant differences were found for all pair-wise comparisons (p < 0.01), except for between control and SCD groups (p = 0.38).
Back to article page